The ranges used for the detection of drug analytes have lower limits and upper limits known as the lower limit of quantification (LLOQ) and the upper limit of quantification (ULOQ) shown in Table 3. These levels were determined based on method validation, sensitivity of the instruments, and the ability of the assay to reduce false negative results significantly compared to SAMHSA levels.1
The purpose of a lower limit is to prevent false negative results, while the upper limit is defined by the range of the calibration curve. Concentrations of an analyte that fall below the LLOQ are reported as “negative,” while those within the range or above the ULOQ are reported as “positive” meaning the analyte is present in that sample.
An internal standard (IS) is used in this assay for the determination of accurate unknown concentrations and is highly important for an assay that tests over 100 analytes. The analytes used are labelled by substituting hydrogens (1H) with deuterium (2H), carbon-12 with carbon-13 (13C), or nitrogen-14 with nitrogen-15 (15N) for separate detection from the true analytes ( Table 4). They have been selected from the full list of analytes, and represent frequently used drugs that elute from the column early or where there are regions of many of analytes eluting at similar relative retention times.1
The analytes that were found to have the greatest matrix effects were also chosen for the internal standard in order to compensate for ion suppression or enhancement to still allow for reproduceable quantification. The internal standard helps differentiate between drug analytes that elute at the same retention time, although one downside of IS use is a decrease in the sensitivity in areas of the ion chromatogram that have a high density of analyte peaks.1 Internal standard is added to every sample as well as each calibrator and quality control during extraction, with the exception of a double blank that has no concentration of analytes as well as no IS in the blank urine matrix.
DRUG CLASS | DETECTION RANGES (ng/mL) | |
Analyte | LLOQ | ULOQ |
Analgesic |
250 |
5000 |
Anesthetics |
10 |
1000 |
Anticonvulsants |
10 |
1000 |
Antidepressants |
1000 | |
Antihistamines |
10 |
1000 |
Antipsychotics |
10 |
1000 |
Barbiturates |
50 |
5000 |
Benzodiazepines |
1000 | |
Cannabinoids |
2.5 |
1000 |
Ethanol |
250 |
5000 |
Illicit |
1000 | |
Miscellaneous |
10 |
1000 |
Muscle Relaxants |
1000 | |
Nicotine |
100 |
1000 |
Opiates |
1000 | |
Oxycodone |
10 |
1000 |
Stimulants |
1000 | |
Z-Drugs |
10 |
1000 |
|
1-3Chlorophenylpiperazine-D8 |
6-Mam-D6 |
7-aminoclonazepam-D4 |
Amitriptyline-D3 |
Amphetamine-D8 |
Aripiprazole-D8 |
Benzoylecgonine-D8 |
Buprenorphine-D4 |
Cocaine-D3 |
Codeine-D6 |
EDDP-D3 |
Fentanyl-D5 |
Fluoxetine-D5 |
Hydrocodone-D6 |
Hydromorphone-D6 |
Lamotrigine-13C-15N4 |
Meprobamate-D7 |
Methadone-D3 |
Methamphetamine-D11 |
Methylphenidate-D9 |
Morphine-D3 |
Naltrexol-D3 |
Norbuprenorphine-D3 |
Norpropoxyphene-D5 |
Nortriptyline-D3 |
Oxycodone-D6 |
Phencyclidine-D5 |
Tramadol-13C-D3 |
Venlafaxine-D6 |
Zopiclone-D4 |